NCT06963502 2025-05-09A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Patients With Advanced Solid TumorsJiangsu Hansoh Pharmaceutical Co., Ltd.Phase 1 Not yet recruiting762 enrolled